Cecelia Miller, PhD
Assistant Professor-Clinical
Phone:
E-mail:
Mailing Address:
Room D426
680 Ackerman Road
Columbus, OH 43202
Biosketch
Cecelia Miller, PhD, is an Assistant Professor-Clinical in the Department of Pathology and serves as Director of the Cytogenetics Laboratory. Dr. Miller earned her PhD in Biomedical Sciences at the Ohio State University, and completed her clinical cytogenetics and molecular genetics fellowship training at Nationwide Children's Hospital. Dr. Miller is a Diplomate of the American Board of Medical Genetics and Genomics with subspecialty certification in the areas of clinical cytogenetics and genomics, as well as clinical molecular genetics and genomics. Dr. Miller’s research interests are in the cytogenetics and molecular genetics of hematologic malignancies.
Board Certifications
American Board of Medical Genetics and Genomics, Clinical Molecular Genetics and Genomics
American Board of Medical Genetics and Genomics, Clinical Cytogenetics and Genomics
Academic and Medical Appointments
2019-Present Assistant Professor-Clinical, Department of Pathology, The Ohio State University, Columbus, OH
2019-Present Director, Cytogenetics Laboratory, The Ohio State University, Columbus, OH
2019-Present Associate Director, Molecular Pathology Laboratory (Genetics), The Ohio State University, Columbus, OH
Education and Training
2016-2019 Clinical Molecular & Cytogenetics Fellowship, Nationwide Children’s Hospital, Columbus, OH
2012-2016 Ph.D., Ohio State University, Columbus, OH
2009-2012 M.S., Ohio State University, Columbus, OH
2003-2006 B.S., Ohio State University, Columbus, OH
Selected Publications
- Miller C, Ruppert AS, Heerema NA, Maddocks KJ, Labanowska J, Breidenbach H, Lozanski G, Zhao W, Gordon A, Jones JA, Flynn JM, Jaglowski SM, Andritsos LA, Blum KA, Awan F, Rogers K, Grever MR, Johnson AJ, Abruzzo L, Hertlein EK, Blachly J, Woyach J & Byrd JB. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib. Blood Advances. 2017; 1(19):1584-1588.
- Miller C, Ruppert AS, Lehman A, Blachly JS, Lucas DM, Grever M, Tallman MS, Flinn IW, Rassenti LZ, Kipps TJ, Sampath D, Byrd JC, Coombes KR & Hertlein EK. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. Oncotarget. 2017; 8:25942-25954
- Miller C, Muthusamy N, Breidenbach H, Puski A, Byrd JC, Heerema N. Metaphase cytogenetics in chronic lymphocytic leukemia. Current Genetic Medicine Reports. 2016; 4:65.
- Miller C, Stephens D, Ruppert AS, Racke F, McFaddin A, Breindenbach H, Lin HJ, Waller K, Bannerman T, Jones JA, Woyach JA, Andritsos LA, Maddocks K, Zhao W, Lozanski G, Flynn JM, Grever M, Byrd JC, and Heerema NA. 2015. Jumping translocations, a novel finding in chronic lymphocytic leukaemia. British Journal of Haematology. 2015; 170(2):200-7.